Li Hui Ping
Li Hui Ping — Chief Physician — Respiratory & Critical Care — Shanghai Pulmonary Hospital
Specialties
Interstitial lung disease, sarcoidosis, diffuse panbronchiolitis, pulmonary infectious diseases, bronchiectasis, bronchial asthma, COPD, as well as the treatment of complex and critical pulmonary diseases
Education
Graduated from Tongji Medical University in 1982 with a bachelor's degree; graduated from Tongji Medical University in 1992 with a master's degree. In 2008, obtained a clinical doctoral degree from Soochow University.
Professional Experience
Li Huiping, female, Chief Physician of the Second Department of Respiratory Medicine, Professor, currently serves as the Vice President of the Pulmonary Hospital affiliated with Tongji University, Director of the Department of Respiratory Medicine, and Director of the Respiratory Disease Research Laboratory. She is a doctoral and master's supervisor at Tongji University and a master's supervisor at Soochow University. She currently holds positions as Deputy Leader of the National Interstitial Disease Group of the Chinese Medical Association, Standing Committee Member of the Respiratory Disease Branch of the Chinese Medical Doctor Association, Leader of the Eastern China Interstitial Disease Collaboration Group, Deputy Director of the Shanghai Pulmonary Society, and Leader of the Interstitial Disease Group. During the SARS outbreak, she served as a member of the Shanghai Expert Advisory Group for SARS Prevention and Leader of the SARS Diagnosis and Treatment Expert Group at Shanghai Pulmonary Hospital. With 29 years of medical experience, she has extensive expertise in the treatment of acute and chronic respiratory failure, bronchial asthma, chronic obstructive pulmonary disease (COPD), respiratory infections, and various complex diseases. She has conducted in-depth research on challenging conditions such as interstitial lung disease, sarcoidosis, refractory lower respiratory tract infections, and diffuse panbronchiolitis. She has undertaken more than ten projects funded by the National Natural Science Foundation, Shanghai Science and Technology Commission, and Health Bureau. A 2003 epidemiological survey conducted in ten large hospitals nationwide showed that Shanghai Pulmonary Hospital treated the highest number of interstitial disease cases in China and had the highest lung biopsy rate. She developed a series of new methods for differentiating sarcoidosis from atypical tuberculosis, increasing the diagnostic accuracy for these two diseases by 74%, reaching an internationally advanced level, and applied for a patent. Diffuse panbronchiolitis currently has the largest number of cases nationwide, and she established a comprehensive treatment method with an efficacy rate of over 95%, earning the third prize in Clinical Medicine from Tongji University. Her research projects on interstitial lung disease have achieved a leading domestic level, and in 2009, she received a Shanghai Medical Science and Technology Award. She has essentially established a de facto interstitial disease diagnosis and treatment center in Eastern China. She pioneered airway challenge tests and allergen screening to assist in the diagnosis of bronchial asthma and has routinely carried out desensitization treatment for bronchial asthma and allergic rhinitis.
Professional Roles
Member of the 11th Shanghai Municipal Committee of the Chinese People's Political Consultative Conference, Deputy to the 12th Shanghai Municipal People's Congress, Standing Committee Member of the Shanghai Municipal Committee of the China National Democratic Construction Association, Chairperson of the Shenkang General Branch of the China National Democratic Construction Association, Deputy to the Yangpu District People's Congress, Executive Member of the Shanghai Women's Federation, etc.